Related Experiment Video
Updated: Jun 11, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage
Michael Dewaele1, Wim Martinet, Noemí Rubio
1Cell Death Research and Therapy Laboratory, Department of Molecular Cell Biology, Faculty of Medicine, Katholieke Universiteit Leuven, Leuven, Belgium.
Abstract:
Reactive oxygen species (ROS) concurrently instigate apoptosis and autophagy pathways, but the link between these processes remains unclear. Because cytotoxic ROS formation is exploited in anticancer therapy, such as in photodynamic therapy (PDT), a better understanding of the complex interplay between autophagy and apoptosis is urgently required. Previously, we reported that ROS generated by PDT with an endoplasmic reticulum (ER)-associated sensitizer leads to loss of ER-Ca(2+) homeostasis, ER stress and apoptosis. Here we show that PDT prompted Akt-mTOR (mammalian target of rapamycin) pathway down-regulation and stimulated macroautophagy (MA) in cancer and normal cells. Overexpression of the antioxidant enzyme glutathione peroxidase-4 reversed mTOR down-regulation and blocked MA progression and apoptosis. Attenuating MA using Atg5 knockdown or 3-methyladenine, reduced clearance of oxidatively damaged proteins and increased apoptosis, thus revealing a cytoprotective role of MA in PDT. Paradoxically, genetic loss of MA improved clearance of oxidized proteins and reduced photokilling. We found that up-regulation of chaperone-mediated autophagy (CMA) in unstressed Atg(-/-) cells compensated for MA loss and increased cellular resistance to PDT. CMA-deficient cells were significantly sensitized to photokilling but were protected against the ER stressor thapsigargin. These results disclose a stress-specific recruitment of autophagy pathways with cytoprotective function and unravel CMA as the dominant defence mechanism against PDT.
Insights
Photodynamic therapy (PDT) induces cell death by generating reactive oxygen species (ROS). This study reveals autophagy
Area of Science:
- Cellular Stress Responses
- Cancer Biology
- Autophagy Research
Background:
- Reactive oxygen species (ROS) play a dual role in cell death, instigating both apoptosis and autophagy.
- The interplay between ROS-induced apoptosis and autophagy remains incompletely understood.
- Photodynamic therapy (PDT) utilizes ROS for cancer treatment, necessitating a clearer grasp of these cellular pathways.
Purpose of the Study:
- To investigate the role of autophagy in cancer cell response to PDT-induced ROS.
- To elucidate the specific autophagy pathways involved in cellular defense against PDT.
- To understand the relationship between macroautophagy (MA) and chaperone-mediated autophagy (CMA) during PDT.
Main Methods:
- Utilized photodynamic therapy (PDT) to generate reactive oxygen species (ROS) in cancer and normal cells.
- Manipulated autophagy pathways using genetic (Atg5 knockdown, Atg(-/-) cells) and pharmacological (3-methyladenine) approaches.
- Assessed cellular responses including apoptosis, protein oxidation, and endoplasmic reticulum (ER) stress.
- Investigated the Akt-mTOR signaling pathway and antioxidant enzyme glutathione peroxidase-4 (GPx4) expression.
Main Results:
- PDT induced Akt-mTOR pathway down-regulation and stimulated macroautophagy (MA) in cells.
- Overexpression of GPx4 reversed mTOR down-regulation, inhibited MA, and reduced apoptosis.
- MA attenuation increased oxidatively damaged proteins and enhanced apoptosis, indicating a cytoprotective role.
- Genetic loss of MA paradoxically improved oxidized protein clearance but reduced photokilling.
- Chaperone-mediated autophagy (CMA) up-regulation compensated for MA loss, conferring resistance to PDT.
- CMA-deficient cells showed increased sensitivity to PDT but resistance to ER stress.
Conclusions:
- Macroautophagy (MA) plays a cytoprotective role in response to PDT-induced oxidative stress.
- Chaperone-mediated autophagy (CMA) acts as the primary defense mechanism against PDT-induced phototoxicity.
- Autophagy pathways are recruited in a stress-specific manner to protect cells, with CMA being dominant against PDT.
- Understanding these distinct autophagy roles is crucial for optimizing PDT efficacy in cancer therapy.
Related Concept Videos
Cellular Injury V: Apoptosis and Autophagy
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
